HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of systemic lupus erythematosus in patients in U.A.E.

Abstract
Twenty-eight SLE patients (Arabs and Asians) in the UAE were studied in this report. The F:M ratio was markedly high; 27:1 in the group as a whole and 21:1 among Arabs. Local patients (Emirians) developed the disease at an earlier age compared to their expatriate Arab compatriots. Arthropathy occurred in 86% and nephropathy in 43% of cases. Next in frequency were leucopenia, mucocutaneous manifestations and serositis. Apart from lupus headache, the other neuro-psychiatric LE were uncommon or not encountered. Anti-cardiolipin syndrome, Sneddon's syndrome, shrunken lung syndrome, sicca complex, thyrotoxicosis and myasthenia gravis were also present in this small group of patients. Their presence reflects the marked heterogeneity displayed by the disease irrespective of the number of cases involved. An unusually high prevalence of anti ds (DNA) antibodies (92.5%) as compared to ANF (82.5%) was detected (P = NS). Anti-Sm antibody occurred in 30% of cases particularly in those patients with lymphadenopathy and fever. There was a relative paucity in the prevalence of anti RNP, Ro and La antibodies in this group. Differences with and similarities to previous reports concerning other populations are also presented.
AuthorsH M al-Attia, S George
JournalClinical rheumatology (Clin Rheumatol) Vol. 14 Issue 2 Pg. 171-5 (Mar 1995) ISSN: 0770-3198 [Print] Germany
PMID7789058 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antibodies, Antinuclear
Topics
  • Adolescent
  • Adult
  • Age Distribution
  • Age of Onset
  • Antibodies, Antinuclear (analysis)
  • Ethnicity
  • Female
  • Humans
  • Lupus Erythematosus, Systemic (epidemiology, ethnology, physiopathology)
  • Male
  • Middle Aged
  • Prevalence
  • Sex Distribution
  • United Arab Emirates (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: